Cancer is now a story of the good, the bad and the ugly – but also hope | Devi Sridhar

What happened

According to The Guardian’s source item, Cancer is now a story of the good, the bad and the ugly – but also hope | Devi Sridhar, It’s natural to focus on breakthroughs, but there are many challenges in Britain and around the world. There is no magic bullet, but there’s room for optimism Cancer causes nearly one in six deaths worldwide every year , some 10 million all told. That is a stunning number, but it also masks the reality that some cancers are more deadly than others. We have become remarkably good at detecting and treating melanoma and prostate cancer , for example, and today five-year survival rates for those cancers are well over 90% in most rich countries. Others, such as pancreatic cancer, are more difficult. In the UK, just over one in 20 people with pancreatic cancer are still alive five years after diagnosis. That is why a new drug for pancreatic cancer, called daraxonrasib and announced at the American Society of Clinical Oncology’s (Asco) annual meeting in Chicago at the weekend, has been met with

Context

The development sits in VINI’s Science file for readers following research, health, climate, space, medicine, and scientific institutions. The original report is linked so readers can check the source account, follow later updates, and compare new coverage against the first published record. The source item is dated 2026-06-01T17:19:30+00:00.

What to watch

Open questions include whether primary sources issue follow-up statements, whether local or market impacts become clearer, and whether additional reporting changes the timeline or adds material context.

Source

Primary source: Cancer is now a story of the good, the bad and the ugly – but also hope | Devi Sridhar via The Guardian. VINI cites and links the source; it does not reproduce the publisher’s full article text without rights clearance.